Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of ReimbursementBusiness Wire • 10/13/21
Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic TestingBusiness Wire • 10/12/21
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology GrowthBusiness Wire • 09/19/21
Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare ConferenceBusiness Wire • 08/26/21
Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & DevelopmentBusiness Wire • 08/25/21
Personalis' (PSNL) CEO John West on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceBusiness Wire • 08/03/21
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma PatientsBusiness Wire • 08/02/21
Earnings Preview: Personalis (PSNL) Q2 Earnings Expected to DeclineZacks Investment Research • 07/28/21
Personalis: Market-Leading Immuno-Oncology Platform Drives Consistent Long-Term GrowthSeeking Alpha • 06/21/21
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran ProgramBusiness Wire • 06/02/21
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics SummitBusiness Wire • 05/18/21
Personalis, Inc. (PSNL) CEO John West on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
Earnings Preview: Personalis (PSNL) Q1 Earnings Expected to DeclineZacks Investment Research • 04/28/21